April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Treatment of Chronic Central Serous Chorioretinopathy With Photodynamic Therapy: Comparison of Steroid Associated and Idiopathic CSR
Author Affiliations & Notes
  • J. E. Kim
    Ophthalmology, The Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin
  • R. Kapur
    Ophthalmology, The Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin
  • T.-G. Lee
    Ophthalmology, The Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin
  • J. Oswald
    Ophthalmology, The Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin
  • D. V. Weinberg
    Ophthalmology, The Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Footnotes
    Commercial Relationships  J.E. Kim, None; R. Kapur, None; T.-G. Lee, None; J. Oswald, None; D.V. Weinberg, None.
  • Footnotes
    Support  Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1330. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. E. Kim, R. Kapur, T.-G. Lee, J. Oswald, D. V. Weinberg; Treatment of Chronic Central Serous Chorioretinopathy With Photodynamic Therapy: Comparison of Steroid Associated and Idiopathic CSR. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1330.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the response of neurosensory detachments (NSD) in chronic central serous chorioretinopathy (CSR) to photodynamic therapy (PDT) and to compare the treatment response in patients with history of steroid use (S) to those without steroid use (NS).

Methods: : Retrospective chart review of patients who received PDT for management of CSR was performed. Primary outcome was resolution of NSD by optical coherence tomography (OCT). Secondary outcomes were improvement in central foveal thickness (CFT), central 1mm macular thickness (CMT), and logmar visual acuity (LogVA). These parameters were evaluated at 3 months (mo), 6 mo, and final visit following PDT. Fisher exact and Mann Whitney U tests were performed to compare binary and continuous data variables respectively.

Results: : There were total of 15 eyes of 15 patients. Preoperative data were as follows: mean LogVA = 0.52, mean CFT=284.1 um, mean CMT= 301.1 um and mean duration of disease was 52 months. After PDT, mean follow-up was 12 months. Improvement with resolution of NSD was noted at 3 mo, 6 mo, and final visit (p= 0.001-0.003) following PDT. A significant improvement was also noted in CMT (p=0.018-0.043) and CFT (p=0.018-0.043) at 3 mo, 6 mo and final visit. No significant improvement in LogVA was noted at 3 mo, 6 mo or final visit. Among 15 patients, there were 9 patients in group S and 6 patients in group NS. Both groups were balanced with regards to preoperative LogVA (NS=0.52, S=0.62), preoperative CFT (NS=290.8 um, S=280.8 um), CMT (NS=305.5 um, S=298.9 um), average duration of symptoms prior to treatment (N=46 mos, S=55 mos), average age at treatment (N=57 years, S=54 years), and gender distribution. However, there was no statistically significant difference in response to treatment between the two groups at any time point.

Conclusions: : PDT is a reasonable treatment option for NSD in chronic CSR, resulting in anatomic improvement. No significant change in VA may be due to chronicity of the disease in this study or there may be a ceiling effect. History of steroid use may not adversely affect treatment outcome with PDT.

Keywords: retina • photodynamic therapy • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×